Jatinder Singh

Jatinder Singh is a highly experienced professional in nonclinical safety and drug development, currently serving as a Senior Research Fellow at Vertex Pharmaceuticals since December 2022. Prior roles include Senior Director and Head of Nonclinical Safety at FORMA Therapeutics, where Jatinder led staff management and nonclinical safety initiatives for Sickle Cell Disease and Oncology. Jatinder's experience extends to senior leadership positions at Blueprint Medicines, ARIAD Pharmaceuticals, Retrophin, AstraZeneca, Genentech, and Pfizer, contributing to significant drug approvals and safety assessments throughout various therapeutic areas. Academically, Jatinder holds a Ph.D. in Environmental Oncology, postdoctoral training in cellular and molecular oncology, and has completed leadership and management programs at Wharton and Harvard Business School.